(Q44041076)

29 November 2017

Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria (English)

1 reference

29 November 2017

1 reference

Alana K Majors

1

1 reference

29 November 2017

Shantanu Sengupta

series ordinal

2

1 reference

29 November 2017

Donald W Jacobsen

series ordinal

3

1 reference

29 November 2017

Reed E Pyeritz

series ordinal

4

1 reference

29 November 2017

1 June 2002

1 reference

Molecular Genetics and Metabolism

29 November 2017

1 reference

29 November 2017

76

1 reference

29 November 2017

2

1 reference

29 November 2017

92-99

1 reference

Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocystinuria. I. A clinical and pathological study of nine subjects in six families

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Vascular Manifestations in Homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Morphologic Studies in a Patient with Homocystinuria due to 5,10-Methylenetetrahydrofolate Reductase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

1 reference

7 January 2021

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Total homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Plasma homocysteine and cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

The oxidant stress of hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Is homocysteine a pro-oxidant?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine inhibits inactivation of factor Va by activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Hydrogen peroxide production during experimental protein glycation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Hyperhomocysteinemia and oxidative stress: time for a reality check?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

The effects of glucose-induced oxidative stress on growth and extracellular matrix gene expression of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Influence of homocysteine on matrix metalloproteinase-2: activation and activity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by a hydrogen peroxide-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900030-6

7 January 2021

10.1016/S1096-7192(02)00030-6

Identifiers

DOI

1 reference

29 November 2017

1 reference